API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/index-pharmaceuticals-discontinues-cobitolimod-phase-iii-program-301995261.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-announces-that-all-patients-needed-for-the-cobitolimod-dose-selection-milestone-have-completed-induction-study-1-of-the-phase-iii-program-conclude-301953209.html
https://www.prnewswire.com/news-releases/positive-results-from-pk-study-with-cobitolimod-selected-as-one-of-the-best-abstracts-for-poster-presentation-at-uegw-index-pharmaceuticals-301906507.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-has-been-granted-a-new-patent-in-europe-for-the-commercial-formulation-of-cobitolimod-301891270.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-announces-positive-results-from-a-pharmacokinetic-pk-study-with-cobitolimod-301772697.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-updates-the-timeline-of-the-phase-iii-study-conclude-with-cobitolimod-301732412.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-announces-successful-interactions-with-the-pmda-for-the-clinical-development-of-cobitolimod-in-japan-301606382.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-gets-new-patent-for-cobitolimod-granted-in-europe-301585586.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-prepares-for-commercialisation-of-cobitolimod-301501630.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-enrols-first-patient-in-the-phase-iii-study-conclude-with-cobitolimod-in-ulcerative-colitis-301431537.html
https://www.prnewswire.com/news-releases/index-pharmaceuticals-strengthens-the-clinical-development-organization-in-preparation-of-the-start-of-the-phase-iii-study-conclude-with-cobitolimod-301360361.html
https://www.prnewswire.com/news-releases/the-lancet-gastroenterology-and-hepatology-publishes-index-pharmaceuticals-results-of-the-phase-iib-study-with-cobitolimod-301146245.html